Wanting on the underlying holdings of the ETFs in our protection universe at ETF Channel, we have now in contrast the buying and selling value of every holding towards the common analyst 12-month ahead goal value, and computed the weighted common implied analyst goal value for the ETF itself. For the Vanguard Mid-Cap Progress ETF (Image: VOT), we discovered that the implied analyst goal value for the ETF based mostly upon its underlying holdings is $267.72 per unit.
With VOT buying and selling at a latest value close to $243.82 per unit, that implies that analysts see 9.80% upside for this ETF trying via to the common analyst targets of the underlying holdings. Three of VOT’s underlying holdings with notable upside to their analyst goal costs are TransUnion (Image: TRU), Veeva Programs Inc (Image: VEEV), and Edwards Lifesciences Corp (Image: EW). Though TRU has traded at a latest value of $101.30/share, the common analyst goal is 11.82% larger at $113.27/share. Equally, VEEV has 11.43% upside from the latest share value of $208.83 if the common analyst goal value of $232.69/share is reached, and analysts on common predict EW to achieve a goal value of $74.62/share, which is 11.36% above the latest value of $67.01. Under is a twelve month value historical past chart evaluating the inventory efficiency of TRU, VEEV, and EW:
Under is a abstract desk of the present analyst goal costs mentioned above:
Title | Image | Current Worth | Avg. Analyst 12-Mo. Goal | % Upside to Goal |
---|---|---|---|---|
Vanguard Mid-Cap Progress ETF | VOT | $243.82 | $267.72 | 9.80% |
TransUnion | TRU | $101.30 | $113.27 | 11.82% |
Veeva Programs Inc | VEEV | $208.83 | $232.69 | 11.43% |
Edwards Lifesciences Corp | EW | $67.01 | $74.62 | 11.36% |
Are analysts justified in these targets, or overly optimistic about the place these shares shall be buying and selling 12 months from now? Do the analysts have a legitimate justification for his or her targets, or are they behind the curve on latest firm and trade developments? A excessive value goal relative to a inventory’s buying and selling value can mirror optimism concerning the future, however will also be a precursor to focus on value downgrades if the targets had been a relic of the previous. These are questions that require additional investor analysis.
10 ETFs With Most Upside To Analyst Targets »
Additionally see:
10 Components Hedge Funds Are Selling
CINC Videos
Institutional Holders of MRAI
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.